Immunoendocrinology of the thymus in chagas disease

NeuroImmunoModulation

Volumn 18, Issue 5, 2011, Pages 328-338

  Pérez, Ana Rosa ^a   Silva Barbosa, Suse Dayse ^c   Roggero, Eduardo ^a,b   Calmon Hamaty, Flavia ^d   Villar, Silvina R ^a   Gutierrez, Fredy R ^e   Silva, João Santana ^e   Savino, Wilson ^d   Bottasso, Oscar ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD ABIERTA INTERAMERICANA   (Argentina)

^c National Cancer Institute   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chagas disease; Glucocorticoids; Regulatory T cells; Thymus atrophy; TNF

Indexed keywords

CHEMOKINE; CORTICOSTERONE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MIGRATION; CHAGAS DISEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; THYMOCYTE; THYMUS; THYMUS ATROPHY; TRYPANOSOMA CRUZI;

ALLERGY AND IMMUNOLOGY; ANTIGENS, CD; CHAGAS DISEASE; CYTOKINES; ENDOCRINOLOGY; GLUCOCORTICOIDS; HUMANS; THYMUS GLAND;

EID: 80053356861     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000329494     Document Type: Article

References (71)

1. World Health Organization (WHO) and Pan American Health Organization (PAHO) Regional Office: The burden of neglected diseases in Latin America and the Caribbean compared with some other communicable diseases. 2007. http://www.paho.org/English/ AD/DPC/CD/psit-nd-graph.htm
2. Rodrigues Coura J, Albajar Viñas P: Chagas disease: A new worldwide challenge. Nature 2010; 465:S6-S7.
3. Coura JR, Borges-Pereira J: Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 2010; 115: 5-13.
4. Engman DM, Leon JS: Pathogenesis of Chagas heart disease: Role of autoimmunity. Acta Trop 2002; 81: 123-132. (Pubitemid 34093802)
5. Tarleton RL: Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 2001; 31: 550-554. (Pubitemid 32382054)
6. Jamieson BD, Douek DC, Killian S, Hultin LE, Scripture-Adams DD, Giorgi JV, Marelli D, Koup RA, Zack JA: Generation of functional thymocytes in the human adult. Immunity 1999; 10: 569-575. (Pubitemid 29262659)
7. Poulin JF, Viswanathan MN, Harris JM, Komanduri KV, Wieder E, Ringuette N, Jenkins M, McCune JM, Sékaly RP: Direct evidence for thymic function in adult humans. J Exp Med 1999; 190: 479-486. (Pubitemid 29395376)
8. Ritter MA, Boyd RL: Development in the thymus: It takes two to tango. Immunol Today 1993; 14: 462-469. (Pubitemid 23271745)
9. Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davidson NJ, Bean AG, Ladyman HM, Ritter MA, Hugo P: The thymic microenvironment. Immunol Today 1993; 14: 445-459. (Pubitemid 23271743)
10. van Ewijk W, Shores EW, Singer A: Crosstalk in the mouse thymus. Immunol Today 1994; 15: 214-217. (Pubitemid 24137974)
11. Besedovsky HO, del Rey A: Immune-neuroendocrine interactions: Facts and hypotheses. Endocr Rev 1996; 17: 64-102.
12. Savino W: The thymus is a common target organ in infectious diseases. PLoS Pathog 2006; 2:e62.
13. Savino W, Leite-de-Moraes MC, Hontebeyrie-Joskowicz M, Dardenne M: Studies on the thymus in Chagas' disease. 1. Changes in the thymic microenvironment in mice acutely infected with Trypanosoma cruzi Eur J Immunol 1989; 19: 1727-1733. (Pubitemid 19243895)
14. Roggero E, Perez A, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Wietzerbin J, Serra E, Revelli S, Bottasso O: Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol 2002; 128: 421-428. (Pubitemid 34639302)
15. Pérez AR, Roggero E, Nicora A, Palazzi J, Besedovsky HO, Del Rey A, Bottasso OA: Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun 2007; 21: 890-900. (Pubitemid 47287791)
16. de Meis J, Morrot A, Farias-de-Oliveira DA, Villa-Verde DM, Savino W: Differential regional immune response in Chagas disease. PLoS Negl Trop Dis 2009; 3:e417.
17. Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Perez AR, Aoki Mdel P, Bottasso O, Guiñazú N, Silva-Barbosa SD, Gea S: Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi Cytokine Growth Factor Rev 2007; 18: 107-124. (Pubitemid 46401432)
18. Zúñiga-Pflücker JC, Jiang D, Lenardo MJ: Requirement for TNF-alpha and IL-1 alpha in fetal thymocyte commitment and differentiation. Science 1995; 268: 1906-1909.
19. Guevara Patino JA, Ivanov VN, Lacy E, Elkon KB, Marino MW, Nikolic-Zugic J: TNFalpha is the critical mediator of the cyclic AMP-induced apoptosis of CD8+4+ doublepositive thymocytes. J Immunol 2000; 164: 1689-1694. (Pubitemid 30108716)
20. Baseta JG, Stutman O: TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset. J Immunol 2000; 165: 5621-5630.
21. Probert L, Keffer J, Corbella P, Cazlaris H, Patsavoudi E, Stephens S, Kaslaris E, Kioussis D, Kollias G: Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol 1993; 151: 1894-1906. (Pubitemid 23235662)
22. Martin S, Bevan MJ: Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol 1997; 27: 2726-2736. (Pubitemid 27453867)
23. Page DM, Roberts EM, Peschon JJ, Hedrick SM: TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J Immunol 1998; 160: 120-133. (Pubitemid 28116723)
24. Murphy M, Pike-Nobile L, Soo VW, Epstein LB: Characterization of TNF receptors on human thymocytes. Thymus 1994-1995; 23: 177-194.
25. Grell M, Scheurich P, Meager A, Pfizenmaier K: TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 1993; 12: 143-148. (Pubitemid 23183559)
26. Grell M, Becke FM, Wajant H, Männel DN, Scheurich P: TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur J Immunol 1998; 28: 257-263. (Pubitemid 28048296)
27. Chen X, Oppenheim JJ: TNF-alpha: An activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr Dir Autoimmun 2010; 11: 119-134.
28. Lima EC, Garcia I, Vicentelli MH, Vassalli P, Minoprio P: Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect Immun 1997;65:457-465. (Pubitemid 27053209)
29. Truyens C, Torrico F, Angelo-Barrios A, Lucas R, Heremans H, De Baetselier P, Carlier Y: The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunol 1995; 17: 561-568. (Pubitemid 26005618)
30. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FG: Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995; 63: 4862-4867.
31. Lima EC, Garcia I, Vicentelli MH, Vassalli P, Minoprio P: Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect Immun 1997; 65: 457-465. (Pubitemid 27053209)
32. Hernández Caselles T, Stutman O: Immune functions of tumor necrosis factor. 1. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic stimulation. J Immunol 1993; 151: 3999-4012. (Pubitemid 23298733)
33. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992; 10: 411-452.
34. Castaños-Velez E, Maerlan S, Osorio LM, Aberg F, Biberfeld P, Orn A, Rottenberg ME: Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun 1998; 66: 2960-2968. (Pubitemid 28261809)
35. Lima EC, Garcia I, Vicentelli MH, Vassalli P, Minoprio P: Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect Immun 1997; 65: 457-465. (Pubitemid 27053209)
36. De Meis J, Mendes-da-Cruz DA, Farias-de-Oliveira DA, Correa-de-Santana E, Pinto-Mariz F, Cotta-de-Almeida V, Bonomo A, Savino W: Atrophy of mesenteric lymph nodes in experimental Chagas disease: Differential role of Fas/Fas-L and TNFR1/TNF pathways. Microbes Infect 2006; 8: 221-231. (Pubitemid 43139310)
37. Besedovsky HO, del Rey A, Klusman I, Furukawa H, Monge Arditi G, Kabiersch A: Cytokines as modulators of the hypothalamuspituitary-adrenal axis. J Steroid Biochem Mol Biol 1991; 40: 613-618.
38. Ader R, Cohen N: Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet 1995; 349: 99-103.
39. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve -An integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
40. Turnbull AV, Rivier CL: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999; 79: 1-71. (Pubitemid 29056948)
41. Sternberg EM: Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 2001; 169: 429-435. (Pubitemid 32536975)
42. Chrousos GP: The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362.
43. Jaffe HL: The influence of the suprarenal gland on the thymus. 2. Direct evidence of regeneration of the involuted thymus following double suprarenalectomy in the rat. J Exp Med 1924; 40: 619-625.
44. Gruber J, Sgonc R, Hu YH, Beug H, Wick G: Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur J Immunol 1994; 24: 1115-1121. (Pubitemid 24132244)
45. Vacchio MS, Papadopoulos V, Ashwell JD: Steroid production in the thymus: Implications for thymocyte selection. J Exp Med 1994; 179: 1835-1846. (Pubitemid 24155664)
46. Vacchio MS, Lee JY, Ashwell JD: Thymusderived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCRmediated thymocyte activation. J Immunol 1999; 163: 1327-1333. (Pubitemid 29352751)
47. Roggero E, Pérez AR, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Besedovsky HO, Bottasso OA, del Rey A: Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol 2006; 190: 495-503. (Pubitemid 44288385)
48. Gagne D, Pons M, Philibert D: RU 38486: A potent antiglucocorticoid in vitro and in vivo. J Steroid Biochem 1985; 23: 247-251. (Pubitemid 15023302)
49. Corrêa-de-Santana E, Paez-Pereda M, Theodoropoulou M, Kenji Nihei O, Gruebler Y, Bozza M, Arzt E, Villa-Verde DM, Renner U, Stalla J, Stalla GK, Savino W: Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice. J Neuroimmunol 2006; 173: 12-22.
50. Cotta-de-Almeida V, Bonomo A, Mendesda-Cruz DA, Riederer I, De Meis J, Lima-Quaresma KR, Vieira-de-Abreu A, Villa-Verde DM, Savino W: Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration. Eur J Immunol 2003; 33: 2439-2448. (Pubitemid 37138976)
51. Silva-Barbosa SD, Cotta-de-Almeida V, Riederer I, De Meis J, Dardenne M, Bonomo A, Savino W: Involvement of laminin and its receptor in abrogation of heart graft rejection by autoreactive T cells from Trypanosoma cruzi -infected mice. J Immunol 1997; 159: 997-1003. (Pubitemid 127484256)
52. Mendes-da-Cruz DA, de Meis J, Cotta-de-Almeida V, Savino W: Experimental Trypanosoma cruzi infection alters the shaping of the central and peripheral T-cell repertoire. Microbes Infect 2003; 5: 825-832. (Pubitemid 36959932)
53. Mendes-da-Cruz DA, Silva JS, Cotta-de-Almeida V, Savino W: Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: Combined role of fibronectin and the chemokines CXCL12 and CCL4. Eur J Immunol 2006; 36: 1486-1493. (Pubitemid 43942138)
54. Cunha-Neto E, Kalil J: Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 2001; 34: 187-192. (Pubitemid 34149809)
55. Belkaid Y: Regulatory T cells and infection: A dangerous necessity. Nat Rev Immunol 2007; 7: 875-888. (Pubitemid 350006238)
56. Vitelli-Avelar DM, Sathler-Avelar R, Massara RL, Borges JD, Lage PS, Lana M, Teixeira-Carvalho A, Dias JC, Eloi-Santos SM, Martins-Filho OA: Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol 2006; 145: 81-92. (Pubitemid 43893936)
57. Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho A, Lage PS, Eloi-Santos SM, Correa-Oliveira R, Martins-Filho OA: Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25high regulatory T lymphocytes. Scand J Immunol 2005; 62: 297-308. (Pubitemid 41413649)
58. Kotner J, Tarleton R: Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun 2007; 75: 861-869. (Pubitemid 46203450)
59. Sales PA Jr, Golgher D, Oliveira RV, Vieira V, Arantes RM, Lannes-Vieira J, Gazzinelli RT: The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect 2008; 10: 680-688.
60. Mariano FS, Gutierrez FR, Pavanelli WR, Milanezi CM, Cavassani KA, Moreira AP, Ferreira BR, Cunha FQ, Cardoso CR, Silva JS: The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 2008; 10: 825-833.
61. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562. (Pubitemid 38680433)
62. Abrahamsohn IA: Cytokines in innate and acquired immunity to Trypanosoma cruzi infection. Braz J Med Biol Res 1998; 31: 117-121. (Pubitemid 128524619)
63. Cardillo F, Voltarelli JC, Reed SG, Silva JS: Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: Role of NK cells. Infect Immun 1996; 64: 128-134. (Pubitemid 26009351)
64. Gutierrez FR, Mineo TW, Pavanelli WR, Guedes PM, Silva JS: The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 2009; 104(suppl 1):236-245.
65. Savino W, Mendes-da-Cruz DA, Silva JS, Dardenne M, Cotta-de-Almeida V: Intrathymic T-cell migration: A combinatorial interplay of extracellular matrix and chemokines? Trends Immunol 2002; 23: 305-313. (Pubitemid 34628774)
66. Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I: Antigen-specific IL-4-and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cell Immunol 1996; 170: 41-53. (Pubitemid 26179892)
67. Lopes MF, Nunes MP, Henriques-Pons A, Giese N, Morse HC 3rd, Davidson WF, Araújo-Jorge TC, DosReis GA: Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur J Immunol 1999;29:81-89. (Pubitemid 29043525)
68. Hardison JL, Kuziel WA, Manning JE, Lane TE: Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi J Infect Dis 2006; 193: 1584-1588. (Pubitemid 43794588)
69. Paiva CN, Figueiredo RT, Kroll-Palhares K, Silva AA, Silvério JC, Gibaldi D, Pyrrho Ados S, Benjamim CF, Lannes-Vieira J, Bozza MT: CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. J Leukoc Biol 2009; 86: 1239-1246.
70. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R: Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 2005; 73: 7960-7966. (Pubitemid 41740281)
71. Henriques-Pons A, De Meis J, Cotta-de-Almeida V, Savino W, Araújo-Jorge TC: Fas and perforin are not required for thymus atrophy induced by Trypanosoma cruzi infection. Exp Parasitol 2004; 107: 1-4. (Pubitemid 38781066)